Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04309409
Title Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma (NivoMela)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University Hospital, Essen
Indications

melanoma

Therapies

Nivolumab

Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.